Suppr超能文献

通过局部输注重组组织型纤溶酶原激活剂成功治疗急性下腔静脉和单侧肾静脉血栓形成

Successful treatment of acute inferior vena cava and unilateral renal vein thrombosis by local infusion of recombinant tissue plasminogen activator.

作者信息

Lam K K, Lui C C

机构信息

Department of Internal Medicine, Chang Gung Memorial Hospital at Kaohsiung, Hsien, Taiwan.

出版信息

Am J Kidney Dis. 1998 Dec;32(6):1075-9. doi: 10.1016/s0272-6386(98)70086-1.

Abstract

Renal vein thrombosis can occur as a complication of nephrotic syndrome. We present the case of a young man with nephrotic syndrome caused by minimal change disease who developed acute inferior vena cava and left renal vein thrombosis. He was treated initially with intravenous heparin. Because of the persistence of severe left flank pain and gross hematuria, local infusion of recombinant tissue plasminogen activator was tried, with resolution of thrombi and subsidence of symptoms. Functional preservation of the involved kidney is good, as indicated by Tc-99m DMSA scan (involved kidney, 47.4%; uninvolved kidney, 52.6%). Anticoagulation is usually recommended as the treatment of choice in renal vein thrombosis. We believe that in cases with critical presentations, such as bilateral involvement, extension into inferior vena cava, acute renal failure, pulmonary embolism or severe flank pain, thrombolytic therapy should be considered as a second-line treatment if good response is not obtained with heparin.

摘要

肾静脉血栓形成可作为肾病综合征的一种并发症出现。我们报告一例由微小病变病引起的肾病综合征年轻男性病例,该患者发生了急性下腔静脉和左肾静脉血栓形成。他最初接受静脉注射肝素治疗。由于严重的左侧腰痛和肉眼血尿持续存在,尝试了局部输注重组组织型纤溶酶原激活剂,血栓溶解且症状缓解。锝-99m二巯基丁二酸(Tc-99m DMSA)扫描显示(患肾,47.4%;未患肾,52.6%),受累肾脏的功能保留良好。抗凝治疗通常被推荐为肾静脉血栓形成的首选治疗方法。我们认为,在出现双侧受累、延伸至下腔静脉、急性肾衰竭、肺栓塞或严重腰痛等危急情况的病例中,如果肝素治疗效果不佳,应考虑将溶栓治疗作为二线治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验